IL109626A0 - Stable quinolone and naphthydridine premix formulations - Google Patents
Stable quinolone and naphthydridine premix formulationsInfo
- Publication number
- IL109626A0 IL109626A0 IL10962694A IL10962694A IL109626A0 IL 109626 A0 IL109626 A0 IL 109626A0 IL 10962694 A IL10962694 A IL 10962694A IL 10962694 A IL10962694 A IL 10962694A IL 109626 A0 IL109626 A0 IL 109626A0
- Authority
- IL
- Israel
- Prior art keywords
- naphthydridine
- quinolone
- stable
- premix formulations
- premix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6244793A | 1993-05-15 | 1993-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL109626A0 true IL109626A0 (en) | 1994-08-26 |
Family
ID=22042549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10962694A IL109626A0 (en) | 1993-05-15 | 1994-05-11 | Stable quinolone and naphthydridine premix formulations |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU6832394A (en) |
IL (1) | IL109626A0 (en) |
WO (1) | WO1994026110A1 (en) |
ZA (1) | ZA943317B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ID21415A (en) | 1997-12-05 | 1999-06-10 | Upjohn Co | QUINOLON MAGNESIUM ANTIBIOTIC COMPOUNDS |
US20090082337A1 (en) * | 2007-09-21 | 2009-03-26 | Srini Venkastesh | Compositions Comprising Quinolone and Methods for Treating or Controlling Infections |
GR1008168B (en) * | 2013-03-14 | 2014-04-08 | "Φαρματεν Α.Β.Ε.Ε.", | Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3831514A1 (en) * | 1988-09-16 | 1990-03-22 | Bayer Ag | PH NEUTRAL WAESSED SOLUTIONS OF CHINOLO CARBON ACIDS |
US5225413A (en) * | 1988-09-16 | 1993-07-06 | Bayer-Aktiengesellschaft | pH-neutral aqueous solutions of quinolone-carboxylic acids |
-
1994
- 1994-05-11 IL IL10962694A patent/IL109626A0/en unknown
- 1994-05-13 WO PCT/US1994/005316 patent/WO1994026110A1/en active Application Filing
- 1994-05-13 AU AU68323/94A patent/AU6832394A/en not_active Abandoned
- 1994-05-13 ZA ZA943317A patent/ZA943317B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU6832394A (en) | 1994-12-12 |
ZA943317B (en) | 1995-01-23 |
WO1994026110A1 (en) | 1994-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9600932D0 (en) | In-alkyl-n-arylpyrimidinamines and derivatives thereof | |
IL111978A0 (en) | Dry-compressed paroxetine formulations and their preparation | |
IL106109A0 (en) | Vaccine compositions and their manufacture | |
GB9525977D0 (en) | Perfluoroelastomeric compositions and methods | |
EP0721328A4 (en) | Camptothecin formulations | |
AU4939693A (en) | Combination pin pad and terminal | |
AU5494294A (en) | Hop extract and use thereof | |
AP9901623A0 (en) | Pharmaceutical formulations comprising amoxocyllin and clavulanate | |
ZA9410235B (en) | Slow-release insect-repellent formulations and uses | |
GB9410252D0 (en) | Galenic formulations | |
GB9214390D0 (en) | Formulations | |
HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
GB9114526D0 (en) | Compositions and use thereof | |
IL109626A0 (en) | Stable quinolone and naphthydridine premix formulations | |
GB9103631D0 (en) | Composition and use | |
GB9722958D0 (en) | Galenical formulations | |
ZA942246B (en) | Novel imidazolo-quinoxalinones their preparation and use | |
GB9216776D0 (en) | Composition and use | |
GB9303098D0 (en) | Burner plaque | |
GB9416404D0 (en) | New use and formulations | |
GB9406858D0 (en) | New use and formulations | |
ZA948902B (en) | P-Hydroxyaniline derivatives their preparation and their use | |
ZA948901B (en) | P-hydroxyaniline derivatives their preparation and their use | |
GB9301251D0 (en) | Pharmaceutical compositions and use therefor | |
GB9315200D0 (en) | New use and compositions |